UK markets close in 1 hour 55 minutes

Epigenomics AG (EPGNF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.5000-2.0000 (-80.00%)
As of 10:30AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in EUR. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-16,291
-12,024
-2,428
-11,686
-17,020
Depreciation & amortisation
2,226
749
419
535
513
Stock-based compensation
38
-35
98
631
873
Change in working capital
-3,317
-705
-988
914
-211
Inventory
75
118
-52
185
45
Other working capital
-13,567
-13,389
-4,187
-9,592
-13,628
Other non-cash items
-54
50
57
35
-107
Net cash provided by operating activities
-12,537
-12,024
-4,152
-9,571
-13,506
Cash flows from investing activities
Investments in property, plant and equipment
-1,030
-1,365
-35
-21
-122
Sales/maturities of investments
-
0
984
0
-
Other investing activities
-
-411
-
-
-
Net cash used for investing activities
-1,344
-1,700
961
3
47
Net change in cash
-14,244
-14,083
18,428
-6,586
-6,339
Cash at beginning of period
18,043
23,049
3,566
10,155
16,487
Cash at end of period
3,799
10,126
23,049
3,566
10,155
Free cash flow
Operating cash flow
-12,537
-12,024
-4,152
-9,571
-13,506
Capital expenditure
-1,030
-1,365
-35
-21
-122
Free cash flow
-13,567
-13,389
-4,187
-9,592
-13,628